Surveillance of Creutzfeldt-Jakob disease in Australia: update to December 2011.
Commun. Dis. Intell., Jun;36(2):E174-9 (2012)
The prion protein preference of sporadic Creutzfeldt-Jakob disease subtypes.
J. Biol. Chem., Oct;287(43):36465-72 (2012)
Prion subcellular fractionation reveals infectivity spectrum, with a high titre-low PrPres level disparity.
Mol Neurodegener., 7:18 (2012)
Loss of maternal CTCF is associated with peri-implantation lethality of Ctcf null embryos.
PLoS ONE., 7(4):e34915 (2012)
Cellular prion protein expression is not regulated by the Alzheimer's amyloid precursor protein intracellular domain.
PLoS ONE., 7(2):e31754 (2012)
Metal attenuating therapies in neurodegenerative disease.
Expert Rev Neurother., Dec;11(12):1717-45 (2011)
Surveillance of Creutzfeldt-Jakob disease in Australia: update to December 2010.
Commun. Dis. Intell., Jun;35(2):149-53 (2011)
Acute exposure to prion infection induces transient oxidative stress progressing to be cumulatively deleterious with chronic propagation in vitro.
Free Radic. Biol. Med., Aug;51(3):594-608 (2011)
Optical imaging detects apoptosis in the brain and peripheral organs of prion-infected mice.
J. Neuropathol. Exp. Neurol., Feb;70(2):143-50 (2011)
Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion.
Nat. Med., Feb;17(2):175-8 (2011)
Novel single base pair COX III subunit deletion of mitochondrial DNA associated with rhabdomyolysis.
J Clin Neurosci., Feb;18(2):290-2 (2011)
Near-infrared fluorescence imaging of apoptotic neuronal cell death in a live animal model of prion disease.
ACS Chem Neurosci., Nov;1(11):720-7 (2010)
14-3-3 protein detection and sporadic CJD: the status quo serves well while awaiting progress.
J. Neurol. Neurosurg. Psychiatr., Nov;81(11):1181 (2010)
Iatrogenic Creutzfeldt-Jakob disease in Australia: time to amend infection control measures for pituitary hormone recipients?
Med. J. Aust., Sep;193(6):366-9 (2010)
Glycosaminoglycan sulphation affects the seeded misfolding of a mutant prion protein.
PLoS ONE., 5(8):e12351 (2010)
Anionic phospholipid interactions of the prion protein N terminus are minimally perturbing and not driven solely by the octapeptide repeat domain.
J. Biol. Chem., Oct;285(42):32282-92 (2010)
Surveillance of Creutzfeldt-Jakob disease in Australia: 2010 update.
Commun. Dis. Intell., Jun;34(2):96-101 (2010)
Manganese chelation therapy extends survival in a mouse model of M1000 prion disease.
J. Neurochem., Jul;114(2):440-51 (2010)
No evidence for prion protein gene locus multiplication in Creutzfeldt-Jakob disease.
Neurosci. Lett., Mar;472(1):16-8 (2010)
Increased proportions of C1 truncated prion protein protect against cellular M1000 prion infection.
J. Neuropathol. Exp. Neurol., Oct;68(10):1125-35 (2009)